|
1
|
Heise K, Bertran E, Andia ME and Ferreccio
C: Incidence and survival of stomach cancer in a high-risk
population of Chile. World J Gastroenterol. 15:1854–1862. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi C, Liu B, Yan J, Liu H, Pan Z, Yao W,
Yan F and Zhang H: Gastric cancer: Preoperative TNM staging with
individually adjusted computed tomography scanning phase. J Comput
Assist Tomogr. 40:160–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
5
|
Smyth EC and Cunningham D: Gastric cancer
in 2012: Defining treatment standards and novel insights into
disease biology. Nat Rev Clin Oncol. 10:73–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dassen AE, Lemmens VE, van de Poll-Franse
LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K
and Coebergh JW: Trends in incidence, treatment and survival of
gastric adenocarcinoma between 1990 and 2007: A population-based
study in the Netherlands. Eur J Cancer. 46:1101–1110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY
and P'eng FK: Surgical mortality, survival and quality of life
after resection for gastric cancer in the elderly. World J Surg.
24:465–472. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yalçin S: The increasing role of
pharmacogenetics in the treatment of gastrointestinal cancers.
Gastrointest Cancer Res. 3:197–203. 2009.PubMed/NCBI
|
|
9
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: Playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang YY, Li L, Ye ZY, Zhao ZS and Yan ZL:
MicroRNA-10b promotes migration and invasion through Hoxd10 in
human gastric cancer. World J Surg Oncol. 13:2592015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
12
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim YK, Yu J, Han TS, Park SY, Namkoong B,
Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN: Functional links
between clustered microRNAs: Suppression of cell-cycle inhibitors
by microRNA clusters in gastric cancer. Nucleic Acids Res.
37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Zhang Y, Shi Y, Dong G, Liang J, Han
Y, Wang X, Zhao Q, Ding J, Wu K and Fan D: MicroRNA-107, an
oncogene microRNA that regulates tumour invasion and metastasis by
targeting DICER1 in gastric cancer. J Cell Mol Med. 15:1887–1895.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang
Q, Chen L, Pang X, Leng W and Bi F: Plasma miR-122 and miR-192 as
potential novel biomarkers for the early detection of distant
metastasis of gastric cancer. Oncol Rep. 31:1863–1870. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meder B, Backes C, Haas J, Leidinger P,
Stähler C, Großmann T, Vogel B, Frese K, Giannitsis E, Katus HA, et
al: Influence of the confounding factors age and sex on microRNA
profiles from peripheral blood. Clin Chem. 60:1200–1208. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Imaoka H, Toiyama Y, Okigami M, Yasuda H,
Saigusa S, Ohi M, Tanaka K, Inoue Y, Mohri Y and Kusunoki M:
Circulating microRNA-203 predicts metastases, early recurrence and
poor prognosis in human gastric cancer. Gastric Cancer. 19:744–753.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akiyoshi S, Fukagawa T, Ueo H, Ishibashi
M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K and Mori M:
Clinical significance of miR-144-ZFX axis in disseminated tumour
cells in bone marrow in gastric cancer cases. Br J Cancer.
107:1345–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Xue H, Zhang J, Suo T, Xiang Y,
Zhang W, Ma J, Cai D and Gu X: MicroRNA-144 inhibits the metastasis
of gastric cancer by targeting MET expression. J Exp Clin Cancer
Res. 34:352015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grépin C, Nemer G and Nemer M: Enhanced
cardiogenesis in embryonic stem cells overexpressing the GATA-4
transcription factor. Development. 124:2387–2395. 1997.PubMed/NCBI
|
|
22
|
Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu
WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated
miR-144/451 cluster in protection against simulated
ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell
Cardiol. 49:841–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin J, Liu B, Li B, Liu Z, Xie X, Lv Z,
Gao S and Guang J: The cyclooxygenase-2 inhibitor celecoxib
attenuates hepatocellular carcinoma growth and c-Met expression in
an orthotopic mouse model. Oncol Res. 19:131–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z, Chen JQ and Liu JL: COX-2
inhibitors and gastric cancer. Gastroenterol Res Pract.
2014:1323202014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lynch J, Meehan MH, Crean J, Copeland J,
Stallings RL and Bray IM: Metastasis suppressor microRNA-335
targets the formin family of actin nucleators. PLoS One.
8:e784282013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Hong L, Chen Z, Nie Y and Fan D:
Epigenetic regulation of microRNAs in gastric cancer. Dig Dis Sci.
59:716–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao Y, Li P, Zhu ST, Yue JP, Ji XJ, Ma D,
Wang L, Wang YJ, Zong Y, Wu YD and Zhang ST: MiR-26a and miR-144
inhibit proliferation and metastasis of esophageal squamous cell
cancer by inhibiting cyclooxygenase-2. Oncotarget. 7:15173–15186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsu KW, Hsieh RH, Huang KH, Fen-Yau Li A,
Chi CW, Wang TY, Tseng MJ, Wu KJ and Yeh TS: Activation of the
Notch1/STAT3/Twist signaling axis promotes gastric cancer
progression. Carcinogenesis. 33:1459–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu JW, Wu JG, Zheng LH, Zhang B, Ni XC, Li
XQ and Jiang BJ: Influencing factors and clinical significance of
the metastatic lymph nodes ratio in gastric adenocarcinoma. J Exp
Clin Cancer Res. 28:552009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsai MM, Wang CS, Tsai CY, Huang HW, Chi
HC, Lin YH, Lu PH and Lin KH: Potential diagnostic, prognostic and
therapeutic targets of MicroRNAs in human gastric cancer. Int J Mol
Sci. 17:E9452016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hersey P and Zhang XD: Treatment
combinations targeting apoptosis to improve immunotherapy of
melanoma. Cancer Immunol Immunother. 58:1749–1759. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao B, Guo J, Miao Y, Jiang Z, Huan R,
Zhang Y, Li D and Zhong J: Detection of miR-106a in gastric
carcinoma and its clinical significance. Clin Chim Acta.
400:97–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Z, Kong Y, Yang W, Ma F, Zhang Y, Ji
S, Ma EM, Liu H, Chen Y and Hua Y: Upregulation of microRNA-34a
enhances the DDP sensitivity of gastric cancer cells by modulating
proliferation and apoptosis via targeting MET. Oncol Rep.
36:2361–2397. 2016.
|
|
37
|
Song B, Yan J, Liu C, Zhou H and Zheng Y:
Tumor suppressor role of miR-363-3p in gastric cancer. Med Sci
Monit. 21:4074–4080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li D, Li Z, Xiong J, Gong B, Zhang G, Cao
C, Jie Z, Liu Y, Cao Y, Yan Y, et al: MicroRNA-212 functions as an
epigenetic-silenced tumor suppressor involving in tumor metastasis
and invasion of gastric cancer through down-regulating PXN
expression. Am J Cancer Res. 5:2980–2997. 2015.PubMed/NCBI
|
|
39
|
Adhim Z, Matsuoka T, Bito T, Shigemura K,
Lee KM, Kawabata M, Fujisawa M, Nibu K and Shirakawa T: In vitro
and in vivo inhibitory effect of three Cox-2 inhibitors and
epithelial-to-mesenchymal transition in human bladder cancer cell
lines. Br J Cancer. 105:393–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Elmets CA, Ledet JJ and Athar M:
Cyclooxygenases: Mediators of UV-induced skin cancer and potential
targets for prevention. J Invest Dermatol. 134:2497–2502. 2014.
View Article : Google Scholar : PubMed/NCBI
|
